News Releases
Bydureon for Type 2 Diabetes Gets FDA Nod
The FDA has approved a new medication that, combined with diet and exercise, is meant to improve blood sugar control in diabetes patients.
FDA Grants Orphan Drug Status to Soliris for Kidney Transplant Patients
The FDA has granted orphan drug designation to a medication to prevent failure of a transplanted kidney immediately after transplantation.
Lemtrada Fails to Win Approval from FDA for MS Rx
A new multiple sclerosis medication has failed to win FDA approval.
FDA Approves New Inhaler for COPD
The FDA has approved a new inhaler for patients with chronic obstructive pulmonary disease (COPD).
Step Forward for Rx to Treat Rare Mental Condition
The FDA has granted "Orphan Drug" status to a medication in the treatment of a rare disorder linked to autism.
Breast Cancer Rx Tested in Phase I Trial
Researchers are constantly testing new medications for various conditions and breast cancer is no exception.
Allergic Rhinitis Rx in FDA Review Process
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today issued the following statement.
Angelcare Baby Monitors Recalled Due to Strangulation Risk
The U.S. Consumer Product Safety Commission (CPSC), in cooperation with Angelcare Monitors Inc.®, of Quebec, Canada, is announcing a voluntary recall to provide cord covers for 600,000 Angelcare Movement and Sound Monitors with Sensor Pads.
Tendex Issues Voluntary Nationwide Recall of P-Boost, NatuRECT Due to Undeclared Active Ingredients
Tendex is voluntarily recalling Lot# F51Q of P-Boost and Lot # F51Q of NatuRECT to the consumer level.
OxyELITE Pro Dietary Supplements Recalled
USPlabs LLC, Dallas, TX is voluntarily conducting a national recall of all lots and sizes of the OxyElite Pro dietary supplement products listed below.